{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:33:10Z","timestamp":1767339190186},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.juro.2018.05.119","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T21:42:19Z","timestamp":1527630139000},"page":"1014-1021","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Association of Aspirin Use with Survival Following Radical Cystectomy"],"prefix":"10.1097","volume":"200","author":[{"given":"Timothy D.","family":"Lyon","sequence":"first","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Frank","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paras H.","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Tarrell","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Cheville","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Jeffrey","family":"Karnes","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Houston","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew K.","family":"Tollefson","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A.","family":"Boorjian","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2018.05.119_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.2004.047100","article-title":"Prostaglandins and cancer","volume":"55","author":"Wang","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.juro.2018.05.119_bib2","doi-asserted-by":"crossref","first-page":"e0152402","DOI":"10.1371\/journal.pone.0152402","article-title":"Aspirin in the treatment of cancer: reductions in metastatic spread and in mortality: a systematic review and meta-analyses of published studies","volume":"11","author":"Elwood","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.juro.2018.05.119_bib3","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1200\/JCO.2017.72.3569","article-title":"Timing of aspirin and other nonsteroidal anti-inflammatory drug use among patients with colorectal cancer in relation to tumor markers and survival","volume":"35","author":"Hua","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2018.05.119_bib4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.eururo.2017.01.044","article-title":"Regular aspirin use and the risk of lethal prostate cancer in the Physicians' Health Study","volume":"72","author":"Downer","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2018.05.119_bib5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/M16-0577","article-title":"Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement. U. S. Preventive Services Task Force","volume":"164","author":"Bibbins-Domingo","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.juro.2018.05.119_bib6","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/carcin\/20.12.2305","article-title":"Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine","volume":"20","author":"Kitayama","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.juro.2018.05.119_bib7","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.juro.2009.06.026","article-title":"Fibrin clot inhibitor medication and efficacy of bacillus Calmette-Guerin for bladder urothelial cancer","volume":"182","author":"Boorjian","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2018.05.119_bib8","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1464-410X.2008.08123.x","article-title":"Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Guerin","volume":"103","author":"Gee","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2018.05.119_bib9","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.juro.2018.05.119_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.juro.2013.02.003","article-title":"Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy","volume":"190","author":"da Silva","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2018.05.119_bib11","doi-asserted-by":"crossref","first-page":"386e7","DOI":"10.1016\/j.urolonc.2015.05.024","article-title":"The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder","volume":"33","author":"Nayan","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2018.05.119_bib12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jnci\/djn485","article-title":"Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials","volume":"101","author":"Cole","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2018.05.119_bib13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat New Biol"},{"key":"10.1016\/j.juro.2018.05.119_bib14","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/carcin\/10.9.1651","article-title":"Responses of rat urine and urothelium to bladder tumor promoters: possible roles of prostaglandin E2 and ascorbic acid synthesis in bladder carcinogenesis","volume":"10","author":"Shibata","year":"1989","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.juro.2018.05.119_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/bjc.2017.393","article-title":"Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression","volume":"118","author":"Kashiwagi","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2018.05.119_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature14034","article-title":"Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance","volume":"517","author":"Kurtova","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.juro.2018.05.119_bib17","first-page":"471","article-title":"Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer","volume":"15","author":"Gee","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1016\/j.juro.2018.05.119_bib18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0022-5347(05)60322-9","article-title":"COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancer","volume":"173","author":"Montie","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2018.05.119_bib19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/01.ju.0000161589.85869.ae","article-title":"Cyclooxygenase-2 inhibition: a potential mechanism for increasing the efficacy of bacillus Calmette-Guerin immunotherapy for bladder cancer","volume":"174","author":"Dovedi","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2018.05.119_bib20","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1073\/pnas.0409783102","article-title":"Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination","volume":"102","author":"De Santo","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.juro.2018.05.119_bib21","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1073\/pnas.1612920114","article-title":"COX2\/mPGES1\/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells","volume":"114","author":"Prima","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.juro.2018.05.119_bib22","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa1613683","article-title":"Pembrolizumab as second-line therapy for advanced urothelial carcinoma","volume":"376","author":"Bellmunt","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2018.05.119_bib23","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.juro.2018.05.119_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/1535-7163.MCT-05-0117","article-title":"Cyclooxygenase inhibitors in urinary bladder cancer: in\u00a0vitro and in\u00a0vivo effects","volume":"5","author":"Mohammed","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.juro.2018.05.119_bib25","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","article-title":"A randomized trial of aspirin to prevent colorectal adenomas","volume":"348","author":"Baron","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2018.05.119_bib26","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.2016.15450","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2018.05.119_bib27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/003335491513000614","article-title":"Preventive aspirin and other antiplatelet medication use among U.S. adults aged >\/= 40 years: data from the National Health and Nutrition Examination Survey, 2011-2012","volume":"130","author":"Gu","year":"2015","journal-title":"Public Health Rep"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534718432971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534718432971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2018.05.119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:41:37Z","timestamp":1651196497000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2018.05.119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1016\/j.juro.2018.05.119"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2018.05.119","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"type":"print","value":"0022-5347"},{"type":"electronic","value":"1527-3792"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Association of Aspirin Use with Survival Following Radical Cystectomy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2018.05.119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}